Showing results (11-20 of 631) with videos related to
Sort By:
Pageof 64
Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society|May 4, 2012
Complications of peristomal recurrence of Crohn's disease: a case report and a review of literatureFrank Hoentjen, Janice C Colwell, Stephen B HanauerJournal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 4, 2008
An updated approach to dysplasia in IBDDavid T RubinThe American Journal of Gastroenterology|October 5, 2013
Curbing our enthusiasm for fecal transplantation in ulcerative colitisDavid T RubinBlood|July 15, 2004
STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cellsFrank Hoentjen, R Balfour Sartor, Michitaka Ozaki, et al.Best Practice & Research. Clinical Gastroenterology|April 7, 2016
Probiotics and prebiotics in ulcerative colitisLauranne A A P Derikx, Levinus A Dieleman, Frank HoentjenJournal of Crohn'S & Colitis|May 14, 2024
Management of Colorectal Neoplasia in IBD Patients: Current Practice and Future PerspectivesMonica E W Derks, Maarten Te Groen, Lisa M A van Lierop, et al.European Journal of Gastroenterology & Hepatology|May 22, 2018
Short article: Recommendations on rectal surveillance for colorectal cancer after subtotal colectomy in patients with inflammatory bowel diseaseLauranne A A P Derikx, Michiel E de Jong, Frank HoentjenNederlands Tijdschrift Voor Geneeskunde|September 21, 2013
[Treatment of patients with severe glucocorticoid-refractory ulcerative colitis: cyclosporine or infliximab?]Mark Löwenberg, Nanne K H de Boer, Pieter Dewint, et al.Journal of Crohn'S & Colitis|June 27, 2020
Immediate Infusion Reaction to Intravenous Ustekinumab in Three Crohn's Disease Patients: A Case Report and Review of the LiteraturePepijn W A Thomas, Gerben Ferwerda, Rachel L West, et al.Current Treatment Options in Gastroenterology|August 12, 2006
Colorectal cancer in inflammatory bowel disease: molecular and clinical considerationsDavid T Rubin, Nimisha ParekhPageof 64